<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2014-3-273-280</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-693</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ИЗУЧЕНИЕ НЕКОТОРЫХ ЦИТОКИНОВ КРОВИ У БОЛЬНЫХ РЕВМАТОИДНЫМ АРТРИТОМ: КЛИНИКО- ИММУНОЛОГИЧЕСКИЕ ВЗАИМОСВЯЗИ</article-title><trans-title-group xml:lang="en"><trans-title>STUDIES OF SEVERAL BLOOD CYTOKINES IN PATIENTS WITH RHEUMATOID ARTHRITIS: CLINICAL AND IMMUNOLOGAL INTERRRELATIONS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пачкунова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pachkunova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., старший лаборант кафедры терапии ГБОУ ВПО «Ярославская государственная медицинская академия» Минздрава России</p></bio><bio xml:lang="en"><p>PhD (Medicine), Senior Laboratory Assistant, Department of Therapy, Institute of Postgraduate Education, Yaroslavl State Medical Academy</p></bio><email xlink:type="simple">pachkunov@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Данилова</surname><given-names>Т. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Danilova</surname><given-names>T. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры терапии ГБОУ ВПО «Ярославская государственная медицинская академия» Минздрава России</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Department of Therapy, Institute of Postgraduate Education, Yaroslavl State Medical Academy</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Феофанова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Feofanovа</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры терапии ГБОУ ВПО «Ярославская государственная медицинская академия» Минздрава России</p></bio><bio xml:lang="en"><p>Research Fellow, Department of Therapy, Institute of Postgraduate Education, Yaroslavl State Medical Academy</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВПО «Ярославская государственная медицинская академия» Минздрава России, г. Ярославль</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Yaroslavl State Medical Academy, Yaroslavl</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>01</day><month>08</month><year>2014</year></pub-date><volume>16</volume><issue>3</issue><fpage>273</fpage><lpage>280</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пачкунова М.В., Данилова Т.Г., Феофанова Е.В., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Пачкунова М.В., Данилова Т.Г., Феофанова Е.В.</copyright-holder><copyright-holder xml:lang="en">Pachkunova M.V., Danilova T.G., Feofanovа E.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/693">https://www.mimmun.ru/mimmun/article/view/693</self-uri><abstract><p>У больных ревматоидным артритом повышено содержание фактора некроза опухоли-αи интерферона-γ крови по сравнению с нормой. Увеличение уровня фактора некроза опухоли-α отмечается по мере роста активности воспалительного процесса, а также у больных с внесуставнымипроявлениями заболевания. Концентрация интерферона-γ достоверно связана с активностью воспалительного процесса и продолжительностью ревматоидного артрита более 1 года. Содержание фактора некроза опухоли-α и интерферона-γ крови взаимосвязано с суставным синдромом и функциональным статусом больных ревматоидным артритом.</p></abstract><trans-abstract xml:lang="en"><p>Blood levels of tumor necrosis factor-α (TNFα) and interferon γ (IFNγ) are shown to be increased in patients with rheumatoid arthritis, as compared to normal values. An increase of TNFα levels is shown to correlate with higher activity of inflammatory process, as well as with extra-articulate lesions in patients. Concentration of IFNγ proved to be significantly connected with activity of inflammatory process, and at later terms of the disorder ( &gt; 1 year). TNFα and IFNγ levels are interconnected with joint lesions and functional scores of patients with rheumatoid arthritis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ревматоидный артрит</kwd><kwd>цитокины</kwd><kwd>фактор некроза опухоли-α</kwd><kwd>интерферон-γ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>rheumatoid arthritis</kwd><kwd>cytokines</kwd><kwd>tumor necrosis factor-α</kwd><kwd>interferon-γ</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Balabanova R.M. Infliksimab: na vse li voprosy polucheny otvety za 10 let? [Infliksimab: whether on everything questions are received answers in 10 years]. Sovremennaya revmatologiya – Modern Rheumatology, 2010, no. 1, pp. 61-65.</mixed-citation><mixed-citation xml:lang="en">Balabanova R.M. Infliksimab: na vse li voprosy polucheny otvety za 10 let? [Infliksimab: whether on everything questions are received answers in 10 years]. Sovremennaya revmatologiya – Modern Rheumatology, 2010, no. 1, pp. 61-65.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Dem`yanov A.V., Kotov A.Yu., Simbirtsev A.S. Diagnosticheskaya tsennost` issledovaniya urovney tsitokinov v klinicheskoy praktike [The diagnostic value of research of levels of cytokines in clinical practice]. Tsitokiny i vospalenie – Cytokines and Inflammation, 2003, vol. 2, no. 3, pp. 20-35.</mixed-citation><mixed-citation xml:lang="en">Dem`yanov A.V., Kotov A.Yu., Simbirtsev A.S. Diagnosticheskaya tsennost` issledovaniya urovney tsitokinov v klinicheskoy praktike [The diagnostic value of research of levels of cytokines in clinical practice]. Tsitokiny i vospalenie – Cytokines and Inflammation, 2003, vol. 2, no. 3, pp. 20-35.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zheleznikova G.F. Rol` gamma-interferona v immunopatogeneze infektsiy [Gamma interferon role in immunopathogenesis infections]. Klinicheskaya laboratornaya diagnostika – Clinical Laboratory Diagnostics, 2008, no. 4, pp. 3-8.</mixed-citation><mixed-citation xml:lang="en">Zheleznikova G.F. Rol` gamma-interferona v immunopatogeneze infektsiy [Gamma interferon role in immunopathogenesis infections]. Klinicheskaya laboratornaya diagnostika – Clinical Laboratory Diagnostics, 2008, no. 4, pp. 3-8.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Karateev D.E. Voprosy bezopasnosti terapii ingibitorami FNO-α [The problems of the safety of therapy with tumor necrosis factor-α inhibitors]. Sovremennaya revmatologiya – Modern Rheumatology, 2009, no. 4, pp. 33-38.</mixed-citation><mixed-citation xml:lang="en">Karateev D.E. Voprosy bezopasnosti terapii ingibitorami FNO-α [The problems of the safety of therapy with tumor necrosis factor-α inhibitors]. Sovremennaya revmatologiya – Modern Rheumatology, 2009, no. 4, pp. 33-38.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ketlinskiy S.A. Tsitokiny [Cytokines]. St. Petersburg, Foliant, 2008, 550 p.</mixed-citation><mixed-citation xml:lang="en">Ketlinskiy S.A. Tsitokiny [Cytokines]. St. Petersburg, Foliant, 2008, 550 p.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kologrivova E.N., Novitskiy V.V., Urazova O.I. Vliyanie persistentsii virusa prostogo gerpesa na produktsiyu tsitokinov immunokompetentnymi kletkami pri revmatoidnom artrite [Influence of herpes simplex virus persistence upon production of cytokines by Immunocompetent cells in rheumatoid arthritis]. Meditsinskaya immunologiya – Medical Immunology, 2009, no. 1, pp. 91-94.</mixed-citation><mixed-citation xml:lang="en">Kologrivova E.N., Novitskiy V.V., Urazova O.I. Vliyanie persistentsii virusa prostogo gerpesa na produktsiyu tsitokinov immunokompetentnymi kletkami pri revmatoidnom artrite [Influence of herpes simplex virus persistence upon production of cytokines by Immunocompetent cells in rheumatoid arthritis]. Meditsinskaya immunologiya – Medical Immunology, 2009, no. 1, pp. 91-94.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Lukina G.V., Sigidin Ya.A., Andreeva L.Yu. Vliyanie antitsitokinovoy terapii na syvorotochnyy uroven`osnovnykh tsitokinov pri revmatoidnom artrite [Impact of anticytokine therapy on serum levels of major cytokines in rheumatoid arthritis]. Nauchno-prakticheskaya revmatologiya – Scientific-Practical Rheumatology, 2005, no. 3, pp. 75.</mixed-citation><mixed-citation xml:lang="en">Lukina G.V., Sigidin Ya.A., Andreeva L.Yu. Vliyanie antitsitokinovoy terapii na syvorotochnyy uroven`osnovnykh tsitokinov pri revmatoidnom artrite [Impact of anticytokine therapy on serum levels of major cytokines in rheumatoid arthritis]. Nauchno-prakticheskaya revmatologiya – Scientific-Practical Rheumatology, 2005, no. 3, pp. 75.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Luchikhina E.L., Karateev D.E. Aktual`nye voprosy primeneniya ingibitorov faktora nekroza opukholi α pri revmatoidnom artrite [Use of tumor necrosis factor-α inhibitors in rheumatoid arthritis: topical aspects]. Sovremennaya revmatologiya – Modern Rheumatology, 2008, no. 4, pp. 46-51.</mixed-citation><mixed-citation xml:lang="en">Luchikhina E.L., Karateev D.E. Aktual`nye voprosy primeneniya ingibitorov faktora nekroza opukholi α pri revmatoidnom artrite [Use of tumor necrosis factor-α inhibitors in rheumatoid arthritis: topical aspects]. Sovremennaya revmatologiya – Modern Rheumatology, 2008, no. 4, pp. 46-51.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lysak N.V., Bugrova O.V., Leyzerman V.G. Immunologicheskie osobennosti rannego revmatoidnogo artrita [Immunological features of early rheumatoid arthritis]. Nauchno-meditsinskiy vestnik Tsentral`nogo Chernozem`ya – Scientific and Medical Messenger of the Central Chernozem Region, 2007, no. 30, pp. 131-136.</mixed-citation><mixed-citation xml:lang="en">Lysak N.V., Bugrova O.V., Leyzerman V.G. Immunologicheskie osobennosti rannego revmatoidnogo artrita [Immunological features of early rheumatoid arthritis]. Nauchno-meditsinskiy vestnik Tsentral`nogo Chernozem`ya – Scientific and Medical Messenger of the Central Chernozem Region, 2007, no. 30, pp. 131-136.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mazurov V.I. Narusheniya immunoregulyatsii pri revmatoidnom artrite i puti ikh korrektsii [Immunoregulation violations at rheumatoid arthritis and way their correction]. Rossiyskie meditsinskie vest – Russian Medical Messages, 2008, vol. 13, no. 2, pp. 77-79.</mixed-citation><mixed-citation xml:lang="en">Mazurov V.I. Narusheniya immunoregulyatsii pri revmatoidnom artrite i puti ikh korrektsii [Immunoregulation violations at rheumatoid arthritis and way their correction]. Rossiyskie meditsinskie vest – Russian Medical Messages, 2008, vol. 13, no. 2, pp. 77-79.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Makovskiy A.A., Mel`nik I.V. Rol` tsitokinov v induktsii sistemnykh proyavleniy revmatoidnogo artrita i sistemnoy krasnoy volchanki [Role cytokines in induction of system manifestations of rheumatoid arthritis and system lupus erythematosus]. Voenno-meditsinskiy zhurnal – Military Medical Journal, 2001, no. 4, pp. 66-67.</mixed-citation><mixed-citation xml:lang="en">Makovskiy A.A., Mel`nik I.V. Rol` tsitokinov v induktsii sistemnykh proyavleniy revmatoidnogo artrita i sistemnoy krasnoy volchanki [Role cytokines in induction of system manifestations of rheumatoid arthritis and system lupus erythematosus]. Voenno-meditsinskiy zhurnal – Military Medical Journal, 2001, no. 4, pp. 66-67.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Nasonov E.L. Farmakoterapiya revmatoidnogo artrita – sovremennye rekomendatsii [Pharmacotherapy of rheumatoid arthritis – modern recommendations]. Vrach – Practitioner, 2007, no. 1, pp. 38-42.</mixed-citation><mixed-citation xml:lang="en">Nasonov E.L. Farmakoterapiya revmatoidnogo artrita – sovremennye rekomendatsii [Pharmacotherapy of rheumatoid arthritis – modern recommendations]. Vrach – Practitioner, 2007, no. 1, pp. 38-42.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nasonova V.A., Lukina G.V., Sigidin Ya.A. Neytralizatsiya IFN-γ – novoe napravlenie v terapii revmatoidnogo artrita [Neutralization IFN-gamma – the new direction in therapy of rheumatoid arthritis]. Terapevticheskiy arkhiv – Therapeutic Archive, 2008, vol. 80, no. 52, pp. 30-37.</mixed-citation><mixed-citation xml:lang="en">Nasonova V.A., Lukina G.V., Sigidin Ya.A. Neytralizatsiya IFN-γ – novoe napravlenie v terapii revmatoidnogo artrita [Neutralization IFN-gamma – the new direction in therapy of rheumatoid arthritis]. Terapevticheskiy arkhiv – Therapeutic Archive, 2008, vol. 80, no. 52, pp. 30-37.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Novikov A.A., Aleksandrova E.N., Diatroptova N.A., Nasonov E.L. Rol` tsitokinov v patogeneze revmatoidnogo artrita [Role cytokines in journal rheumatoid arthritis]. Nauchno-prakticheskaya revmatologiya –Scientific Practical Rheumatology, 2010, no. 2, pp. 71-82.</mixed-citation><mixed-citation xml:lang="en">Novikov A.A., Aleksandrova E.N., Diatroptova N.A., Nasonov E.L. Rol` tsitokinov v patogeneze revmatoidnogo artrita [Role cytokines in journal rheumatoid arthritis]. Nauchno-prakticheskaya revmatologiya –Scientific Practical Rheumatology, 2010, no. 2, pp. 71-82.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Novikov A.A., Aleksandrova E.N., Diatroptova N.A., Nasonov E.L. Mul`tipleksnyy analiz tsitokinovogo profilya syvorotki krovi i sinovial`noy zhidkosti u bol`nykh rannim revmatoidnym artritom [The multiplex analysis of a profile of cytokines of serum of blood and synovial liquid at patients early rheumatoid arthritis]. Klinicheskaya laboratornaya diagnostika – Clinical Laboratory Diagnostics, 2010, no. 9, p. 51.</mixed-citation><mixed-citation xml:lang="en">Novikov A.A., Aleksandrova E.N., Diatroptova N.A., Nasonov E.L. Mul`tipleksnyy analiz tsitokinovogo profilya syvorotki krovi i sinovial`noy zhidkosti u bol`nykh rannim revmatoidnym artritom [The multiplex analysis of a profile of cytokines of serum of blood and synovial liquid at patients early rheumatoid arthritis]. Klinicheskaya laboratornaya diagnostika – Clinical Laboratory Diagnostics, 2010, no. 9, p. 51.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Revmatologiya: natsional`noe rukovodstvo. Nasonova E.L., Nasonovoy V.A. [Rheumatology: national management. Ed. Nasonov E.L. Nasonova B.A.]. Moscow, GEOTAR-Media, 2008. 720 p.</mixed-citation><mixed-citation xml:lang="en">Revmatologiya: natsional`noe rukovodstvo. Nasonova E.L., Nasonovoy V.A. [Rheumatology: national management. Ed. Nasonov E.L. Nasonova B.A.]. Moscow, GEOTAR-Media, 2008. 720 p.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Topicheva Z.S., Gladilin G.P., Zryachkin N.I. Dinamika aktivnosti tsitokinov syvorotki krovi bol`nykh revmatoidnym artritom [Dynamics of activity cytokines serum of blood of patients with rheumatoid arthritis]. Saratovskiy nauchno-meditsinskiy zhurnal – Saratov Scientific and Medical Journal, 2008, vol. 4, no. 22, pp. 56-58.</mixed-citation><mixed-citation xml:lang="en">Topicheva Z.S., Gladilin G.P., Zryachkin N.I. Dinamika aktivnosti tsitokinov syvorotki krovi bol`nykh revmatoidnym artritom [Dynamics of activity cytokines serum of blood of patients with rheumatoid arthritis]. Saratovskiy nauchno-meditsinskiy zhurnal – Saratov Scientific and Medical Journal, 2008, vol. 4, no. 22, pp. 56-58.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Atzeni F., Sarzi-Puttini P. Early rheumatoid arthritis. Reumatismo, 2007, vol. 59, no. 2, pp. 100-117.</mixed-citation><mixed-citation xml:lang="en">Atzeni F., Sarzi-Puttini P. Early rheumatoid arthritis. Reumatismo, 2007, vol. 59, no. 2, pp. 100-117.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Billiau A. Interferon-γ in autoimmunity. Cytokine Growth Factor Rev., 1996, vol. 7, no. 1, pp. 25-34.</mixed-citation><mixed-citation xml:lang="en">Billiau A. Interferon-γ in autoimmunity. Cytokine Growth Factor Rev., 1996, vol. 7, no. 1, pp. 25-34.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Bingham Clifton O.J. The Pathogenesis of rheumatoid arthritis: Pivotal cytokines involved in bone degradation and inflammation. J. Rheumatol., 2002, vol. 29, no. 65, pp. 3-9.</mixed-citation><mixed-citation xml:lang="en">Bingham Clifton O.J. The Pathogenesis of rheumatoid arthritis: Pivotal cytokines involved in bone degradation and inflammation. J. Rheumatol., 2002, vol. 29, no. 65, pp. 3-9.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bradley J.R. TNF-mediated inflammatory disease. J. Pathol., 2008, vol. 214, no. 1, pp. 149-160.</mixed-citation><mixed-citation xml:lang="en">Bradley J.R. TNF-mediated inflammatory disease. J. Pathol., 2008, vol. 214, no. 1, pp. 149-160.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Crow M.K. Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res Ther., 2010, vol. 12, no. 1, p. 5.</mixed-citation><mixed-citation xml:lang="en">Crow M.K. Type I interferon in organ-targeted autoimmune and inflammatory diseases. Arthritis Res Ther., 2010, vol. 12, no. 1, p. 5.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">David J.P., Schett G. TNF and bone. Curr Dir Autoimmun., 2010, vol. 11, pp. 135-144.</mixed-citation><mixed-citation xml:lang="en">David J.P., Schett G. TNF and bone. Curr Dir Autoimmun., 2010, vol. 11, pp. 135-144.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Dayer J.M. Interleukin 1 or tumor necrosis factor alpha: Which is the real target in rheumatoid arthritis? J. Rheumatol., 2002, vol. 29, no. 65, pp. 10-15.</mixed-citation><mixed-citation xml:lang="en">Dayer J.M. Interleukin 1 or tumor necrosis factor alpha: Which is the real target in rheumatoid arthritis? J. Rheumatol., 2002, vol. 29, no. 65, pp. 10-15.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Dolhain R.J., ter Haar N.T., Hoefakker S., Tak P.P., de Ley M., Claassen E., Breedveld F.C., Miltenburg A.M. Increased expression of interferon (IFN)-gamma together with IFN-gamma receptor in the rheumatoid synovial membrane comparedwith synovium of patients with osteoarthritis. Br. J. Rheumatol., 1996, vol. 35, no. 1, pp. 24-32.</mixed-citation><mixed-citation xml:lang="en">Dolhain R.J., ter Haar N.T., Hoefakker S., Tak P.P., de Ley M., Claassen E., Breedveld F.C., Miltenburg A.M. Increased expression of interferon (IFN)-gamma together with IFN-gamma receptor in the rheumatoid synovial membrane comparedwith synovium of patients with osteoarthritis. Br. J. Rheumatol., 1996, vol. 35, no. 1, pp. 24-32.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Doodes D., Cao Y., Hamel K.M., Wang Y., Rodeghero R.L., Mikecz K., Glant T.T., Iwakura Y., Finnegan A. IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis. J. Immunol., 2010, vol. 184, no. 3, pp. 1552-1559.</mixed-citation><mixed-citation xml:lang="en">Doodes D., Cao Y., Hamel K.M., Wang Y., Rodeghero R.L., Mikecz K., Glant T.T., Iwakura Y., Finnegan A. IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis. J. Immunol., 2010, vol. 184, no. 3, pp. 1552-1559.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Feldmann M., Maini S.R. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol. Rev., 2008, vol. 223, no. 6, pp. 7-19.</mixed-citation><mixed-citation xml:lang="en">Feldmann M., Maini S.R. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol. Rev., 2008, vol. 223, no. 6, pp. 7-19.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Gottenberg J.E., Chiocchia G. Dendritic cells and interferon-mediated autoimmunity. Biochimie, 2007, vol. 89, no. 6-7, pp. 856-871.</mixed-citation><mixed-citation xml:lang="en">Gottenberg J.E., Chiocchia G. Dendritic cells and interferon-mediated autoimmunity. Biochimie, 2007, vol. 89, no. 6-7, pp. 856-871.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Kunz M., Ibrahim S.M. Non-major histocompatibility complex rheumatoid arthritis susceptibility genes. Crit. Rev. Immunol., 2011, vol. 31, no. 2, pp. 99-114.</mixed-citation><mixed-citation xml:lang="en">Kunz M., Ibrahim S.M. Non-major histocompatibility complex rheumatoid arthritis susceptibility genes. Crit. Rev. Immunol., 2011, vol. 31, no. 2, pp. 99-114.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Manadan A.M., Block J.A. Rheumatoid arthritis: beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade. Am. J. Ther., 2008, vol. 15, no. 1, pp. 53-58.</mixed-citation><mixed-citation xml:lang="en">Manadan A.M., Block J.A. Rheumatoid arthritis: beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade. Am. J. Ther., 2008, vol. 15, no. 1, pp. 53-58.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">McInnes I.B., O’Dell J.R. State-of-the-art: rheumatoid arthritis. Ann. Rheum. Dis., 2010, vol. 69, no. 11, pp. 1898-1906.</mixed-citation><mixed-citation xml:lang="en">McInnes I.B., O’Dell J.R. State-of-the-art: rheumatoid arthritis. Ann. Rheum. Dis., 2010, vol. 69, no. 11, pp. 1898-1906.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Meyer O. Interferons and autoimmune disorders. Joint Bone Spine, 2009, vol. 76, no. 5, pp. 464-473.</mixed-citation><mixed-citation xml:lang="en">Meyer O. Interferons and autoimmune disorders. Joint Bone Spine, 2009, vol. 76, no. 5, pp. 464-473.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Michaud K., Wolfe F. Reduced mortality among rheumatoid arthritis patients treated with anti- TNF therapy and methotrexate. Ann. Rheum. Dis., 2004, vol. 50, no. 12, p. 4095.</mixed-citation><mixed-citation xml:lang="en">Michaud K., Wolfe F. Reduced mortality among rheumatoid arthritis patients treated with anti- TNF therapy and methotrexate. Ann. Rheum. Dis., 2004, vol. 50, no. 12, p. 4095.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Okamoto H., Hoshi D., Kiire A., Yamanaka H., Kamatani N. Molecular targets of rheumatoid arthritis. Inflamm. Allergy Drug Targets, 2008, vol. 7, no. 1, pp. 53-66.</mixed-citation><mixed-citation xml:lang="en">Okamoto H., Hoshi D., Kiire A., Yamanaka H., Kamatani N. Molecular targets of rheumatoid arthritis. Inflamm. Allergy Drug Targets, 2008, vol. 7, no. 1, pp. 53-66.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ursaciuc C., Surcel M., Ciotaru D., Dobre M., Pirvu I.R., Munteanu A.N., Alecu M., Huică R. Regulatory T cells and TH1/TH2 cytokines as immunodiagnosis keys in systemic autoimmune diseases. Roum. Arch. Microbiol. Immunol., 2010, vol. 69, no. 2, pp. 79-84.</mixed-citation><mixed-citation xml:lang="en">Ursaciuc C., Surcel M., Ciotaru D., Dobre M., Pirvu I.R., Munteanu A.N., Alecu M., Huică R. Regulatory T cells and TH1/TH2 cytokines as immunodiagnosis keys in systemic autoimmune diseases. Roum. Arch. Microbiol. Immunol., 2010, vol. 69, no. 2, pp. 79-84.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Wallet M.A., Wallet S.M., Guiulfo G., Sleasman J.W., Goodenow M.M. IFNgamma primes macrophages for inflammatory activation by high molecular weight hyaluronan. Cell Immunol., 2010, vol. 262, no. 2, pp. 84-88.</mixed-citation><mixed-citation xml:lang="en">Wallet M.A., Wallet S.M., Guiulfo G., Sleasman J.W., Goodenow M.M. IFNgamma primes macrophages for inflammatory activation by high molecular weight hyaluronan. Cell Immunol., 2010, vol. 262, no. 2, pp. 84-88.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
